CHARACTERISTICS OF PEDIATRIC NEUROGENIC BLADDER PATIENTS AT HASAN SADIKIN HOSPITAL PERIOD 2019 -2024
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: The purpose of this study was to characterize pediatric neurogenic bladder patients in order to recognize, treat, and avoid the related problems. Material & Methods: a retrospective study was conducted in the urology department's at Hasan Sadikin Hospital in Bandung, Indonesia. Data from pediatric neurogenic bladder patients who had urodynamic tests performed during the study period were evaluated. Results: Participants were predominantly female with 7 subjects (58.3%) while there were 5 male subjects (41.7%). The mean age of patients was 9.2 ± 5.44 years. Conservative management was the course of treatment for 10 patients (83.3%). The majority of this patient's bladder capacity—10 participants, or 83.33% of the total—have small capacities of less than 250. Seven patients (58.33%) had normal contractility, according to the bladder contractility index (BCI) inspection. Up to 7 participants (58.3%) had detrusor sphincter dyssynergia (DSD). Conclusion: Pediatric neurogenic bladder patients typically have small bladder capacities, according to urodynamic examination results. The most common symptoms that patients experience was those related to incontinence. The fundamental principle of treatment for children with neurogenic bladder is conservative therapy. Understanding the characteristics of neurogenic bladder patients and routinely carrying out urodynamic examinations allows early detection and appropriate treatment for this condition. Keywords: Pediatric, neurogenic bladder, urodynamic, incontinence.
##plugins.themes.bootstrap3.article.details##
Pediatric, neurogenic bladder, urodynamic, incontinence.
Perez NE, Godbole NP, Amin K, Syan R, Gater DR. Neurogenic Bladder Physiology, Pathogenesis, and Management after Spinal Cord Injury. J Pers Med. 2022 Jun;12(6):968.
Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012;2012:816274.
Hamid R, Averbeck MA, Chiang H, Garcia A, Al Mousa RT, Oh S-J, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018 Oct;36(10):1517–27.
Sturm RM, Cheng EY. The Management of the Pediatric Neurogenic Bladder. Curr Bladder Dysfunct Rep. 2016;11:225–33.
Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski RR, Goehring EL, Nguyen-Khoa B-A, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn. 2011 Mar;30(3):395–401.
Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care. 2013;19(10 Suppl):s191-6.
Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009 Jul;56(1):81–8.
Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012 Dec;188(6 Suppl):2455–63.
Hobbs KT, Krischak M, Tejwani R, Purves JT, Wiener JS, Routh JC. The Importance of Early Diagnosis and Management of Pediatric Neurogenic Bladder Dysfunction. Res reports Urol. 2021;13:647–57.
Gormley EA. Urologic complications of the neurogenic bladder. Urol Clin North Am. 2010 Nov;37(4):601–7.
Akid FHK, Missaoui AM, Belhoul M, Belabed W, Chahaider C, Salah D Ben, et al. Prevalence and clinical manifestations of neurogenic bladder dysfunction in type 2 diabetes: a population-based survey. Endocr Abstr. 2022 May;
Panicker JN. Neurogenic Bladder: Epidemiology, Diagnosis, and Management. Semin Neurol. 2020 Oct;40(5):569–79.
Kavanagh A, Baverstock R, Campeau L, Carlson K, Cox A, Hickling D, et al. Canadian Urological Association guideline: Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Executive summary. Can Urol Assoc J. 2019 Jun;13(6):156–65.
Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol. 2008 May;23(5):717–25.
Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol. 2008 Apr;23(4):541–51.
Widia F, Indraswari MT, Rahardjo HE. Characteristics of neurogenic lower urinary tract dysfunction patients at Cipto Mangunkusumo Hospital. Med J Indones. 2023 Jun;32(1):31–7.
Townsend MK, Danforth KN, Lifford KL, Rosner B, Curhan GC, Resnick NM, et al. Incidence and remission of urinary incontinence in middle-aged women. Am J Obstet Gynecol. 2007 Aug;197(2):167.e1-5.
Griebling TL. Urinary incontinence in the elderly. Clin Geriatr Med. 2009 Aug;25(3):445–57.
Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, Soto-Vega E. A comprehensive review of urologic complications in patients with diabetes. Springerplus. 2014 Dec;3(1):549.
Golbidi S, Laher I. Bladder dysfunction in diabetes mellitus. Front Pharmacol. 2010;1:136.
Sager C, Barroso Jr. U, Murillo B. Netto J, Retamal G, Ormaechea E. Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. Int braz j urol. 2022 Jan;48(1):31–51.
Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, Speer MC, et al. Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):662–9.
Wu CQ, Franco I. Management of vesicoureteral reflux in neurogenic bladder. Investig Clin Urol. 2017 Jun;58(Suppl 1):S54–8.
Vaidyanathan S, Selmi F, Abraham KA, Hughes P, Singh G, Soni B. Hydronephrosis and renal failure following inadequate management of neuropathic bladder in a patient with spinal cord injury: Case report of a preventable complication. Patient Saf Surg. 2012 Sep;6(1):22.
Guo K, Zhao D. The correlation between GFR and unit renal volume in infants with hydronephrosis measured by two imaging methods. Sci Rep. 2023 Nov;13(1):19556.
Ludwikowski BM, Bieda JC, Lingnau A, González R. Surgical management of neurogenic sphincter incompetence in children. Front Pediatr. 2019;7(MAR):1–8.